Skip to main content

Together we are beating cancer

Donate now

News

Showing 12 out of 2993 results
HPV vaccine

Long awaited study results have confirmed that the quadrivalent human papillomavirus (HPV) vaccine substantially reduces invasive cervical cancer risk.   Long awaited study results have confirmed that the quadrivalent human papillomavirus (HPV) vaccine substantially reduces invasive cervical cancer risk.  

by Cancer Research UK | News | 1 October 2020

1 October 2020

Lung cancer cell

The National Institute for Health and Care Excellence has approved the drug osimertinib to treat some adults in England with untreated, advanced lung cancer. The National Institute for Health and Care Excellence has approved the drug osimertinib to treat some adults in England with untreated, advanced lung cancer.

by Cancer Research UK | News | 11 September 2020

11 September 2020

antibody crystal structure

Researchers in Cambridge have pioneered the development of an innovative affinity maturation technique to generate high-affinity antibody against Arginase 2. Researchers in Cambridge have pioneered the development of an innovative affinity maturation technique to generate high-affinity antibody against Arginase 2.

by Cancer Research UK | News | 3 September 2020

3 September 2020